Old Web
English
Sign In
Acemap
>
authorDetail
>
Paul Andriaan Jan Janssen
Paul Andriaan Jan Janssen
Johnson & Johnson Pharmaceutical Research and Development
Virology
Chemistry
Drug
Pharmacology
Medicine
4
Papers
341
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
TMC125, a Novel Next-Generation Nonnucleoside Reverse Transcriptase Inhibitor Active against Nonnucleoside Reverse Transcriptase Inhibitor-Resistant Human Immunodeficiency Virus Type 1
2004
Antimicrobial Agents and Chemotherapy
Koen Andries
Hilde Azijn
Theo Thielemans
Donald Ludovici
Michael Kukla
Jan Heeres
Paul Andriaan Jan Janssen
Bart L. De Corte
Johan Vingerhoets
Rudi Pauwels
Marie-Pierre de Béthune
Show All
Source
Cite
Save
Citations (311)
A pharmacophore docking algorithm and its application to the cross‐docking of 18 HIV‐NNRTI's in their binding pockets
2003
Proteins
Frits Daeyaert
Marc de Jonge
Jan Heeres
Luc Koymans
Paul J. Lewi
Maarten H. Vinkers
Paul Andriaan Jan Janssen
Show All
Source
Cite
Save
Citations (30)
Evolution of anti-HIV drug candidates diaryltriazines (DATA) analogs
2001
Bioorganic & Medicinal Chemistry Letters
Donald Ludovici
Robert W. Kavash
M. Kukla
Chih Yung Ho
Hong Ye
B. de Corte
Koenraad Jozef Lodewijk Marcel Andries
Tibotec
Paul Andriaan Jan Janssen
Show All
Source
Cite
Save
Citations (0)
Inhibiting pyrimidines of hiv replication.
1999
Koenraad Jozef Lodewijk Marcel Andries
Bart de Cort
Marc René De Jonge
Jan Heeres
Chih-Yung. Ho
Paul Andriaan Jan Janssen
Robert W. Kavash
Lucien Maria Henricus Koymans
Michael Joseph Kukla
Donald W. Ludovici
Koen Jeanne Alfons Van Aken
Show All
Source
Cite
Save
Citations (0)
1